Discover 644 paid clinical trials in Charlotte, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Charlotte offers many opportunities to participate in clinical research focused on various conditions, including cancer, lymphoma, heart disease, and cystic fibrosis. The city’s medical research institutions are recruiting both healthy volunteers interested in paid trials, as well as individuals with specific health conditions.
Filter
2
Filter results
Results: 644
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
for
Myelofibrosis, Post-PV MF, Post-ET Myelofibrosis,
Location: Charlotte NC, Winston-Salem NC, Durham NC, Wilson NC,
Sponsor: Kartos Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06479135
Phase3, Recruiting
A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With REGN5678 for Adult Participants With Advanced Prostate Cancer
for
Metastatic Castration-resistant Prostate Cancer
Location: Charlotte NC, Louisville KY, Columbus OH, Baltimore MD,
Sponsor: Regeneron Pharmaceuticals
Sex: Male
Age: 18+
Code: NCT05125016
Phase1, Phase2, Recruiting
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
for
High-Risk Non-Muscle-Invasive Bladder Cancer
Location: Charlotte NC, Lisle IL, Chapel Hill NC, Raleigh NC,
Sponsor: CG Oncology, Inc.
Sex: All
Age: 18+
Code: NCT06567743
Phase2, Recruiting
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
for
Mantle Cell Lymphoma, B Cell Lymphoma
Location: Charlotte NC, Winston-Salem NC, Durham NC,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06742996
Phase3, Recruiting
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
for
Triple-Negative Breast Cancer
Location: Charlotte NC, Fayetteville NC, Midlothian VA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06393374
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
for
Carcinoma, Squamous Cell
Location: Charlotte NC, Chapel Hill NC, Atlanta GA,
Sponsor: Johnson & Johnson Enterprise Innovation Inc.
Sex: All
Age: 60+
Code: NCT04892173
Phase3, Recruiting
A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
for
Graft-versus-host Disease (GVHD)
Location: Charlotte NC, Chapel Hill NC, Durham NC, Charleston SC,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT06615050
Phase3, Recruiting
A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product
for
Hematological Malignancy, Solid Tumor Malignancy
Location: Charlotte NC, Cincinnati OH, Baltimore MD, Seattle WA
Sponsor: Century Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05768269
Recruiting
X-ray Psoralen Activated Cancer Therapy in Head and Neck, Breast, Sarcoma and Melanoma
for
Advanced Solid Tumor Cancer
Location: Charlotte NC, Greenville SC, Durham NC,
Sponsor: Immunolight, LLC
Sex: All
Age: 18+
Code: NCT04389281
Phase1, Recruiting
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
for
Multiple Myeloma
Location: Charlotte NC, Atlanta GA, Nashville TN, Pittsburgh PA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT05201781
Recruiting
Cancer-related Fatigue During Maintenance Immunotherapy for Non-small Cell Lung Cancer (NSCLC): a Qualitative Study
for
Non-small Cell Lung Cancer
Location: Charlotte NC, Winston-Salem NC
Sponsor: Wake Forest University Health Sciences
Sex: All
Age: 18+
Code: NCT06567704
Recruiting
Patient Descriptors Of Cancer-Related Fatigue: A Mixed Methods Pilot Study Of Cancer Survivors
for
Cancer, Fatigue
Location: Charlotte NC, Winston-Salem NC
Sponsor: Wake Forest University Health Sciences
Sex: All
Age: 18+
Code: NCT06634381
Recruiting
Digoxin Medulloblastoma Study
for
Medulloblastoma, Medulloblastoma, Non-WNT/Non-SHH
Location: Charlotte NC, Chapel Hill NC, Lexington KY,
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Sex: All
Age: 1 - 30
Code: NCT06701812
Phase2, Recruiting
A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft Tissue